- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Silicon Biosystems, S.p.A., a provider of specialized molecular and cell biology technology, today announced that it has formed a U.S. subsidiary operation, Silicon Biosystems, Inc.,to be headquartered in San Diego, California.
The newly formed business will focus on commercial operations and the development of the North American research and clinical diagnostics markets for the company's DEPArray™ technology platform.
"The formation of our own commercial operation in the U.S. represents a significant step forward for our business," stated Giuseppe Giorgini, CEO of Silicon Biosystems, S.p.A. "Our DEPArray™ platform will allow clinicians and researchers working to advance personalized medicine in areas such as clinical oncology to identify new biomarkers and improve patient treatment based on genetic information they have previously not had access to. We are excited to begin commercial discussions with thought leaders in the U.S."
The company's DEPArray™ technology exploits microelectronics and the principles of dielectrophoresis to isolate and manipulate cells in a suspension matrix. The approach, patented by Silicon Biosystems, offers the unique possibility of controlling individual cells and micro-particles inside a disposable cartridge. The DepArray™ platform makes it possible to find, sort, select and separate individual cells for further analysis or culturing.
About Silicon Biosystems
Silicon Biosystems, S.p.A. is based in Bologna Italy and has developed a set of proprietary solutions called lab-on-a-chip technologies, targeted at miniaturized cell-biology testing. Silicon Biosystems is one of the most innovative start-ups in the field of "lab-on-a-chip," based on active substrates, as testified by a number of awards and recognitions. The company is also an industrial member of the nano2Life EC Network of Excellence on nanobiotechnologies.
For more information, please click here
(619) 814-2370, x11
Copyright © Silicon BiosystemsIf you have a comment, please Contact us.
|Related News Press|
News and information
Blue Star Opportunities Corp. (BSTO) Completes Major Condo Building Project in Manhattan Residential Area; Company Now Has the Resources to Service the Largest of Construction Projects April 21st, 2015
DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015
Haydale Announce Dedicated Graphene Inks Manufacturing Capability March 25th, 2015
LamdaGen Corporation Launches Taiwan Diagnostic Subsidiary March 19th, 2015
Rafts on the cell membrane: Researchers from TU Wien (Vienna) shed light on a big secret of cell membranes: The 'lipid rafts', which have been believed to move within the cell membrane, do not really exist April 21st, 2015